Patents by Inventor Ernst Reichmann

Ernst Reichmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tissue graft
    Patent number: 10953140
    Abstract: The present invention is directed to a method of producing a tissue graft, comprising at least steps of providing a gel, seeding the gel with cells of at least a first and/or cells of a second type, and culturing of the cells of the first and/or cells of the second type in said gel until the formation of at least one first biostructure in the gel by the cells of the first type and/or the cells of the second type.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: March 23, 2021
    Assignee: UNIVERSITAT ZURICH
    Inventors: Ernst Reichmann, Daniela Marino, Agnieszka Sylwia Klar
  • Device and method for compressing a hydrogel
    Patent number: 10195310
    Abstract: The invention relates to a device and a method for compressing a hydrogel layer (H), wherein a separate piston (600) that is designed to be connected to a second component (400) of the device in a releasable manner in an operating mode of the device, particularly by means of a latching connection, presses along a compression direction (C) against said hydrogel layer (H) residing on a membrane bottom (501) of a graft frame (500) so as to compress the hydrogel layer (H) between the piston (600) and the membrane bottom (501).
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: February 5, 2019
    Assignee: UNIVERSITÄT ZÜRICH
    Inventor: Ernst Reichmann
  • TISSUE GRAFT
    Publication number: 20170258965
    Abstract: The present invention is directed to a method of producing a tissue graft, comprising at least steps of providing a gel, seeding the gel with cells of at least a first and/or cells of a second type, and culturing of the cells of the first and/or cells of the second type in said gel until the formation of at least one first biostructure in the gel by the cells of the first type and/or the cells of the second type.
    Type: Application
    Filed: July 29, 2014
    Publication date: September 14, 2017
    Applicant: UNIVERSITAT ZURICH
    Inventors: Ernst REICHMANN, Daniela MARINO, Agnieszka Sylwia KLAR
  • DEVICE AND METHOD FOR COMPRESSING A HYDROGEL
    Publication number: 20160136333
    Abstract: The invention relates to a device and a method for compressing a hydrogel layer (H), wherein a separate piston (600) that is designed to be connected to a second component (400) of the device in a releasable manner in an operating mode of the device, particularly by means of a latching connection, presses along a compression direction (C) against said hydrogel layer (H) residing on a membrane bottom (501) of a graft frame (500) so as to compress the hydrogel layer (H) between the piston (600) and the membrane bottom (501).
    Type: Application
    Filed: June 27, 2014
    Publication date: May 19, 2016
    Inventor: Ernst REICHMANN
  • Pharmaceutical compositions for treating tumour diseases
    Publication number: 20020127542
    Abstract: Pharmaceutical compositions containing as active compound a substance which inhibits the activity of TGF&bgr; on tumour cells of epithelial origin, for the treatment of epithelial, invasive tumour diseases which are characterised by a reversible transition of the cells from an epithelial, non-invasive state into a fibroblastoid, invasive state. The pharmaceutical composition contains a TGF&bgr; inhibitor, preferably combined with an Ras inhibitor. Process for screening substances for the treatment of epithelial, invasive tumour diseases.
    Type: Application
    Filed: March 1, 2002
    Publication date: September 12, 2002
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Hartmut Beug, Martin Oft, Ernst Reichmann, Karl-Heinz Heider
  • Methods of screening for pharmacologically active compounds for the treatment of tumour diseases
    Patent number: 6383733
    Abstract: Pharmaceutical compositions containing as active compound a substance which inhibits the activity of TGF&bgr; on tumour cells of epithelial origin, for the treatment of epithelial, invasive tumour diseases which are characterized by a reversible transition of the cells from an epithelial, non-invasive state into a fibroblastoid, invasive state. The pharmaceutical composition contains a TGF&bgr; inhibitor, preferably combined with an Ras inhibitor. Process for screening substances for the treatment of epithelial, invasive tumour diseases.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: May 7, 2002
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Hartmut Beug, Martin Oft, Ernst Reichmann, Karl-Heinz Heider